Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

Research output: Contribution to journalConference abstract in journal

Original languageEnglish
Article number179
JournalDiabetologia
Volume64
Issue numberSUPPL 1
Pages (from-to)95-95
ISSN0012-186X
DOIs
Publication statusPublished - 2021

ID: 286499015